Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity

BACKGROUND: Interleukin-35 (IL-35) has been reported to play an important role in the progression of cancers. The role of IL-35 in prostate cancer (PCA) is not well understood. In this study, we investigated the effects of IL-35 on PCA and its immunoregulatory effect on PCA. METHODS: The protein and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jialin, Wang, Yan, Li, Dai, Zhang, Haonan, Guo, Zhi, Yang, Xueling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541216/
https://www.ncbi.nlm.nih.gov/pubmed/33041668
http://dx.doi.org/10.1186/s12935-020-01583-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541216/
https://www.ncbi.nlm.nih.gov/pubmed/33041668
http://dx.doi.org/10.1186/s12935-020-01583-3

Ejemplares similares